About
Personalized T cell-based immunotherapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalStem Cell & Cellular Therapy
Clinical Trials (17)
View allTotal Trials
17
As Lead Sponsor
16
As Collaborator
1
Total Enrollment
1,194
By Phase
PHASE1: 7PHASE1/PHASE2: 4PHASE2/PHASE3: 1PHASE4: 1PHASE2: 3PHASE3: 1
By Status
COMPLETED: 13TERMINATED: 2NOT_YET_RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
Today
Hover over trial bars to see details
Recent Trials
NCT06748872Lead Sponsor
EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma
PHASE1Not yet recruiting
55 participants
Started: Jul 1, 2025 · Completed: Aug 1, 2042
NCT04464889Lead Sponsor
HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation
PHASE1Withdrawn
Started: Jul 2, 2020 · Completed: Jul 31, 2025
NCT03503968Lead Sponsor
TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms
PHASE1/PHASE2Terminated
9 participants
Started: Mar 27, 2018 · Completed: Jul 15, 2022
NCT02405338Lead Sponsor
DC Vaccination for Post-remission Therapy in AML
PHASE1/PHASE2Completed
20 participants
Started: Mar 31, 2015 · Completed: Nov 30, 2019
NCT02029352Collaborator
Topical Green Tea Ointment in Treatment of Superficial Skin Cancer
PHASE2/PHASE3Completed
42 participants
Started: Nov 30, 2014 · Completed: Feb 29, 2016
Locations (1)
Headquarters
Planegg-Martinsried, Germany
Map
Loading map...